chr1-216097080-T-C

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2

The NM_206933.4(USH2A):​c.4758+3A>G variant causes a splice donor region, intron change. The variant allele was found at a frequency of 0.000568 in 1,613,506 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00076 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00055 ( 10 hom. )

Consequence

USH2A
NM_206933.4 splice_donor_region, intron

Scores

2
Splicing: ADA: 0.9624
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:11

Conservation

PhyloP100: 4.49
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.
BP6
Variant 1-216097080-T-C is Benign according to our data. Variant chr1-216097080-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 156396.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-216097080-T-C is described in Lovd as [Benign]. Variant chr1-216097080-T-C is described in Lovd as [Likely_benign]. Variant chr1-216097080-T-C is described in Lovd as [Likely_pathogenic]. Variant chr1-216097080-T-C is described in Lovd as [Pathogenic]. Variant chr1-216097080-T-C is described in Lovd as [Pathogenic]. Variant chr1-216097080-T-C is described in Lovd as [Likely_pathogenic].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000761 (116/152358) while in subpopulation EAS AF= 0.0183 (95/5190). AF 95% confidence interval is 0.0153. There are 0 homozygotes in gnomad4. There are 72 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
USH2ANM_206933.4 linkuse as main transcriptc.4758+3A>G splice_donor_region_variant, intron_variant ENST00000307340.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
USH2AENST00000307340.8 linkuse as main transcriptc.4758+3A>G splice_donor_region_variant, intron_variant 1 NM_206933.4 P1O75445-1
USH2AENST00000674083.1 linkuse as main transcriptc.4758+3A>G splice_donor_region_variant, intron_variant O75445-3

Frequencies

GnomAD3 genomes
AF:
0.000782
AC:
119
AN:
152240
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0185
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00151
AC:
378
AN:
249948
Hom.:
5
AF XY:
0.00142
AC XY:
192
AN XY:
135234
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000398
Gnomad EAS exome
AF:
0.0181
Gnomad SAS exome
AF:
0.000786
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.000151
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000548
AC:
801
AN:
1461148
Hom.:
10
Cov.:
31
AF XY:
0.000583
AC XY:
424
AN XY:
726850
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.000459
Gnomad4 EAS exome
AF:
0.0147
Gnomad4 SAS exome
AF:
0.00113
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000612
Gnomad4 OTH exome
AF:
0.000630
GnomAD4 genome
AF:
0.000761
AC:
116
AN:
152358
Hom.:
0
Cov.:
33
AF XY:
0.000966
AC XY:
72
AN XY:
74508
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0183
Gnomad4 SAS
AF:
0.00103
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000283
Hom.:
0
Bravo
AF:
0.00107
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 20, 2018This variant is associated with the following publications: (PMID: 25445212, 25404053, 30245029, 29625443, 31180159, 31904091, 32090030, 32893482, 33090715) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024USH2A: BS1 -
Usher syndrome type 2A Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.Jun 24, 2020- -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 23, 2017- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 22, 2017c.4758+3A>G in intron 22 of USH2A: This variant is not expected to have clinical significance because it has been identified in 1.9% (348/18756) of East Asian c hromosomes, including 4 homozygotes, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs117798425). ACMG/AMP Criteria applie d: BA1. -
Leber congenital amaurosis Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingMolecular Diagnostics Laboratory, Seoul National University HospitalSep 18, 2014- -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsFeb 10, 2022- -
Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
USH2A-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 26, 2024This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.24
CADD
Benign
19
DANN
Benign
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.96
dbscSNV1_RF
Pathogenic
0.84
SpliceAI score (max)
0.41
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.41
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117798425; hg19: chr1-216270422; API